Europe Frozen Tissues Samples Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Frozen Normal Tissue Samples, Frozen Tumor Tissue Samples, and Frozen Diseased Tissue Samples), Application (Disease Diagnosis & Treatment, Cancer & Other Diseases Research, and Morphological Analysis), and End User (Academic & Research Institutes, Hospitals & Clinics, Diagnostic Centers, and Others)

The frozen tissues samples market in Europe is expected to grow from US$ 13.45 million in 2021 to US$ 30.32 million by 2028; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028.

According to data published by Cancer Research UK in 2020, ~0.16 million people in the UK die each year due to cancer. Moreover, as per the Globocan report, in 2020, breast cancer in females surpassed the number of lung cancer cases to become the most diagnosed cancer, with an estimated 2.3 million new cases (11.7%). This type was followed by lung cancer, colorectal cancer, prostate cancer, and stomach cancer with the detection rates of 11.4%, 10.0%, 7.3%, and 5.6%, respectively. Overall incidence was 2-fold to 3-fold higher in transitioned than transitioning countries. However, death rates for female breast and cervical cancers were considerably higher in transitioning than transitioned countries. Such a high prevalence of cancer is driving the need for research and study of frozen tissue samples. The studies conducted using frozen tumor tissue samples establish several diagnosis and treatment scopes for this chronic condition.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe frozen tissues samples market at a notable CAGR during the forecast period.

 Europe Frozen Tissues Samples Market Revenue and Forecast to 2028 (US$ Million)

Europe Frozen Tissues Samples Market Segmentation

The Europe frozen tissues samples market is segmented on the basis of product type, application, end user, and country. The market, based on product, is segmented into frozen normal tissues samples, frozen tumor tissues samples, and frozen diseased tissue samples. The frozen tissue tumor samples segment held the largest share of the market in 2021. Based on application, the Europe frozen tissues samples market is segmented into disease diagnosis and treatment, cancer and other diseases research, and morphological analysis. In 2021, the cancer and other diseases research segment accounted for the largest share of the market. The Europe frozen tissues samples market, by end user, is segmented into academic and research institutes, hospitals and clinics, diagnostic centers, and others. In 2021, the academic and research institutes segment held the largest market share. Based on country, the Europe frozen tissues samples market is segmented into France, Germany, Italy, UK, Russia, and Rest of Europe.

AMS Biotechnology Ltd.; Audubon Bioscience Co; Bay Biosciences LLC; BioChain Institute Inc.; OriGene Technologies, Inc.; ProteoGenex, Inc.; REPROCELL Inc.; and ZenBio, Inc. are among the leading companies in the Europe frozen tissues samples market.  

1. AMS Biotechnology Ltd.
2. Audubon Bioscience Co
3. Bay Biosciences LLC
4. BioChain Institute Inc.
5. OriGene Technologies, Inc.
6. ProteoGenex, Inc.
7. REPROCELL Inc.
8. ZenBio, Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe frozen tissues samples market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe frozen tissues samples market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the frozen tissues samples market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution